[Comparative changes in PaO2 in moderately hypoxemic COPD patients treated with almitrine versus placebo for one year].
Górecka
D
D
Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Polska, Varsovie, Pologne.
Sliwinski
P
P
Palasiewicz
G
G
Pachocki
R
R
Zielinski
J
J
D000368:Aged; D015765:Almitrine / Q000494:pharmacology*; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood*; D010919:Placebos; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D019141:Respiratory System Agents / Q000494:pharmacology*; D016896:Treatment Outcome
D010919:Placebos; D019141:Respiratory System Agents; D015765:Almitrine; D010100:Oxygen
Evolution comparative de la PaO2 chez des patients BPCO modérément hypoxémiques traités par almitrine versus placebo pendant un an.